Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 2013; Volume 41,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ait-Oudhia, Sihem

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074

B

  1. Backes, Wayne L.

    1. You have access
      Relationship between CYP1A2 Localization and Lipid Microdomain Formation as a Function of Lipid Composition
      Lauren M. Brignac-Huber, James R. Reed, Marilyn K. Eyer and Wayne L. Backes
      Drug Metabolism and Disposition November 2013, 41 (11) 1896-1905; DOI: https://doi.org/10.1124/dmd.113.053611
  2. Bao, Jing Q.

    1. You have access
      Metformin Sinusoidal Efflux from the Liver Is Consistent with Negligible Biliary Excretion and Absence of Enterohepatic Cycling
      Maciej J. Zamek-Gliszczynski, Jing Q. Bao, Jeffrey S. Day and J. William Higgins
      Drug Metabolism and Disposition November 2013, 41 (11) 1967-1971; DOI: https://doi.org/10.1124/dmd.113.053025
  3. Benet, Leslie Z.

    1. You have access
      The Nonenzymatic Reactivity of the Acyl-Linked Metabolites of Mefenamic Acid toward Amino and Thiol Functional Group Bionucleophiles
      Howard Horng and Leslie Z. Benet
      Drug Metabolism and Disposition November 2013, 41 (11) 1923-1933; DOI: https://doi.org/10.1124/dmd.113.053223
  4. Bertino, Joseph S.

    1. You have access
      Endogenous 4β-Hydroxycholesterol-to-Cholesterol Ratio Is Not a Validated Biomarker for the Assessment of CYP3A Activity
      Joseph D. Ma, Anne N. Nafziger and Joseph S. Bertino
      Drug Metabolism and Disposition November 2013, 41 (11) 1972; DOI: https://doi.org/10.1124/dmd.113.054361
  5. Brauch, Hiltrud

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405
  6. Brignac-Huber, Lauren M.

    1. You have access
      Relationship between CYP1A2 Localization and Lipid Microdomain Formation as a Function of Lipid Composition
      Lauren M. Brignac-Huber, James R. Reed, Marilyn K. Eyer and Wayne L. Backes
      Drug Metabolism and Disposition November 2013, 41 (11) 1896-1905; DOI: https://doi.org/10.1124/dmd.113.053611
  7. Brouwer, Kim L. R.

    1. You have access
      Determination of Intracellular Unbound Concentrations and Subcellular Localization of Drugs in Rat Sandwich-Cultured Hepatocytes Compared with Liver Tissue
      Nathan D. Pfeifer, Kevin B. Harris, Grace Zhixia Yan and Kim L. R. Brouwer
      Drug Metabolism and Disposition November 2013, 41 (11) 1949-1956; DOI: https://doi.org/10.1124/dmd.113.052134

C

  1. Chen, Hao

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704
  2. Chen, Min

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704
  3. Chen, Peng

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704

D

  1. Day, Jeffrey S.

    1. You have access
      Metformin Sinusoidal Efflux from the Liver Is Consistent with Negligible Biliary Excretion and Absence of Enterohepatic Cycling
      Maciej J. Zamek-Gliszczynski, Jing Q. Bao, Jeffrey S. Day and J. William Higgins
      Drug Metabolism and Disposition November 2013, 41 (11) 1967-1971; DOI: https://doi.org/10.1124/dmd.113.053025

E

  1. Eyer, Marilyn K.

    1. You have access
      Relationship between CYP1A2 Localization and Lipid Microdomain Formation as a Function of Lipid Composition
      Lauren M. Brignac-Huber, James R. Reed, Marilyn K. Eyer and Wayne L. Backes
      Drug Metabolism and Disposition November 2013, 41 (11) 1896-1905; DOI: https://doi.org/10.1124/dmd.113.053611

F

  1. Forrest, Alan

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074

G

  1. Gross, Annette S.

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074

H

  1. Han, Shasha

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704
  2. Harris, Kevin B.

    1. You have access
      Determination of Intracellular Unbound Concentrations and Subcellular Localization of Drugs in Rat Sandwich-Cultured Hepatocytes Compared with Liver Tissue
      Nathan D. Pfeifer, Kevin B. Harris, Grace Zhixia Yan and Kim L. R. Brouwer
      Drug Metabolism and Disposition November 2013, 41 (11) 1949-1956; DOI: https://doi.org/10.1124/dmd.113.052134
  3. Higgins, J. William

    1. You have access
      Metformin Sinusoidal Efflux from the Liver Is Consistent with Negligible Biliary Excretion and Absence of Enterohepatic Cycling
      Maciej J. Zamek-Gliszczynski, Jing Q. Bao, Jeffrey S. Day and J. William Higgins
      Drug Metabolism and Disposition November 2013, 41 (11) 1967-1971; DOI: https://doi.org/10.1124/dmd.113.053025
  4. Horng, Howard

    1. You have access
      The Nonenzymatic Reactivity of the Acyl-Linked Metabolites of Mefenamic Acid toward Amino and Thiol Functional Group Bionucleophiles
      Howard Horng and Leslie Z. Benet
      Drug Metabolism and Disposition November 2013, 41 (11) 1923-1933; DOI: https://doi.org/10.1124/dmd.113.053223

I

  1. Ishizuka, Tomoko

    1. You have access
      Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
      Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama and Takashi Izumi
      Drug Metabolism and Disposition November 2013, 41 (11) 1888-1895; DOI: https://doi.org/10.1124/dmd.113.053595
  2. Izumi, Takashi

    1. You have access
      Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
      Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama and Takashi Izumi
      Drug Metabolism and Disposition November 2013, 41 (11) 1888-1895; DOI: https://doi.org/10.1124/dmd.113.053595

J

  1. Jiang, Haoran

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704

K

  1. Klein, Kathrin

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405
  2. Kobayashi, Yasuna

    1. You have access
      Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide
      Noriko Kohyama, Hisae Shiokawa, Masayuki Ohbayashi, Yasuna Kobayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition November 2013, 41 (11) 1883-1887; DOI: https://doi.org/10.1124/dmd.113.051854
  3. Kohyama, Noriko

    1. You have access
      Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide
      Noriko Kohyama, Hisae Shiokawa, Masayuki Ohbayashi, Yasuna Kobayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition November 2013, 41 (11) 1883-1887; DOI: https://doi.org/10.1124/dmd.113.051854
  4. Krynetskiy, Evgeny

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405

L

  1. Landersdorfer, Cornelia B.

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
  2. Li, Hua

    1. You have access
      Identification and Characterization of Psoralen and Isopsoralen as Potent CYP1A2 Reversible and Time-Dependent Inhibitors in Human and Rat Preclinical Studies
      Xiao-Mei Zhuang, Yu-Huan Zhong, Wei-Bin Xiao, Hua Li and Chuang Lu
      Drug Metabolism and Disposition November 2013, 41 (11) 1914-1922; DOI: https://doi.org/10.1124/dmd.113.053199
  3. Lu, Chuang

    1. You have access
      Identification and Characterization of Psoralen and Isopsoralen as Potent CYP1A2 Reversible and Time-Dependent Inhibitors in Human and Rat Preclinical Studies
      Xiao-Mei Zhuang, Yu-Huan Zhong, Wei-Bin Xiao, Hua Li and Chuang Lu
      Drug Metabolism and Disposition November 2013, 41 (11) 1914-1922; DOI: https://doi.org/10.1124/dmd.113.053199

M

  1. Ma, Joseph D.

    1. You have access
      Endogenous 4β-Hydroxycholesterol-to-Cholesterol Ratio Is Not a Validated Biomarker for the Assessment of CYP3A Activity
      Joseph D. Ma, Anne N. Nafziger and Joseph S. Bertino
      Drug Metabolism and Disposition November 2013, 41 (11) 1972; DOI: https://doi.org/10.1124/dmd.113.054361
  2. McLachlan, Andrew J.

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
  3. Murayama, Nobuyuki

    1. You have access
      Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
      Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama and Takashi Izumi
      Drug Metabolism and Disposition November 2013, 41 (11) 1888-1895; DOI: https://doi.org/10.1124/dmd.113.053595
  4. Mürdter, Thomas E.

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405

N

  1. Nafziger, Anne N.

    1. You have access
      Endogenous 4β-Hydroxycholesterol-to-Cholesterol Ratio Is Not a Validated Biomarker for the Assessment of CYP3A Activity
      Joseph D. Ma, Anne N. Nafziger and Joseph S. Bertino
      Drug Metabolism and Disposition November 2013, 41 (11) 1972; DOI: https://doi.org/10.1124/dmd.113.054361

O

  1. Ohbayashi, Masayuki

    1. You have access
      Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide
      Noriko Kohyama, Hisae Shiokawa, Masayuki Ohbayashi, Yasuna Kobayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition November 2013, 41 (11) 1883-1887; DOI: https://doi.org/10.1124/dmd.113.051854

P

  1. Perera, Vidya

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074
  2. Pfeifer, Nathan D.

    1. You have access
      Determination of Intracellular Unbound Concentrations and Subcellular Localization of Drugs in Rat Sandwich-Cultured Hepatocytes Compared with Liver Tissue
      Nathan D. Pfeifer, Kevin B. Harris, Grace Zhixia Yan and Kim L. R. Brouwer
      Drug Metabolism and Disposition November 2013, 41 (11) 1949-1956; DOI: https://doi.org/10.1124/dmd.113.052134
  3. Precht, Jana C.

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405

R

  1. Reed, James R.

    1. You have access
      Relationship between CYP1A2 Localization and Lipid Microdomain Formation as a Function of Lipid Composition
      Lauren M. Brignac-Huber, James R. Reed, Marilyn K. Eyer and Wayne L. Backes
      Drug Metabolism and Disposition November 2013, 41 (11) 1896-1905; DOI: https://doi.org/10.1124/dmd.113.053611

S

  1. Schroth, Werner

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405
  2. Schwab, Matthias

    1. You have access
      The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7
      Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab and Thomas E. Mürdter
      Drug Metabolism and Disposition November 2013, 41 (11) 1906-1913; DOI: https://doi.org/10.1124/dmd.113.053405
  3. Shiokawa, Hisae

    1. You have access
      Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide
      Noriko Kohyama, Hisae Shiokawa, Masayuki Ohbayashi, Yasuna Kobayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition November 2013, 41 (11) 1883-1887; DOI: https://doi.org/10.1124/dmd.113.051854

W

  1. Wu, Xianggen

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704

X

  1. Xiao, Wei-Bin

    1. You have access
      Identification and Characterization of Psoralen and Isopsoralen as Potent CYP1A2 Reversible and Time-Dependent Inhibitors in Human and Rat Preclinical Studies
      Xiao-Mei Zhuang, Yu-Huan Zhong, Wei-Bin Xiao, Hua Li and Chuang Lu
      Drug Metabolism and Disposition November 2013, 41 (11) 1914-1922; DOI: https://doi.org/10.1124/dmd.113.053199
  2. Xu, Hongmei

    1. You have access
      A Pharmacometric Approach to Investigate the Impact of Methylxanthine Abstinence and Caffeine Consumption on CYP1A2 Activity
      Vidya Perera, Annette S. Gross, Alan Forrest, Cornelia B. Landersdorfer, Hongmei Xu, Sihem Ait-Oudhia and Andrew J. McLachlan
      Drug Metabolism and Disposition November 2013, 41 (11) 1957-1966; DOI: https://doi.org/10.1124/dmd.113.053074

Y

  1. Yamamoto, Toshinori

    1. You have access
      Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide
      Noriko Kohyama, Hisae Shiokawa, Masayuki Ohbayashi, Yasuna Kobayashi and Toshinori Yamamoto
      Drug Metabolism and Disposition November 2013, 41 (11) 1883-1887; DOI: https://doi.org/10.1124/dmd.113.051854
  2. Yan, Grace Zhixia

    1. You have access
      Determination of Intracellular Unbound Concentrations and Subcellular Localization of Drugs in Rat Sandwich-Cultured Hepatocytes Compared with Liver Tissue
      Nathan D. Pfeifer, Kevin B. Harris, Grace Zhixia Yan and Kim L. R. Brouwer
      Drug Metabolism and Disposition November 2013, 41 (11) 1949-1956; DOI: https://doi.org/10.1124/dmd.113.052134
  3. Yoshigae, Yasushi

    1. You have access
      Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
      Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama and Takashi Izumi
      Drug Metabolism and Disposition November 2013, 41 (11) 1888-1895; DOI: https://doi.org/10.1124/dmd.113.053595

Z

  1. Zamek-Gliszczynski, Maciej J.

    1. You have access
      Metformin Sinusoidal Efflux from the Liver Is Consistent with Negligible Biliary Excretion and Absence of Enterohepatic Cycling
      Maciej J. Zamek-Gliszczynski, Jing Q. Bao, Jeffrey S. Day and J. William Higgins
      Drug Metabolism and Disposition November 2013, 41 (11) 1967-1971; DOI: https://doi.org/10.1124/dmd.113.053025
  2. Zang, Xinjie

    1. You have access
      Expression of Efflux Transporters in Human Ocular Tissues
      Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han and Xianggen Wu
      Drug Metabolism and Disposition November 2013, 41 (11) 1934-1948; DOI: https://doi.org/10.1124/dmd.113.052704
  3. Zhong, Yu-Huan

    1. You have access
      Identification and Characterization of Psoralen and Isopsoralen as Potent CYP1A2 Reversible and Time-Dependent Inhibitors in Human and Rat Preclinical Studies
      Xiao-Mei Zhuang, Yu-Huan Zhong, Wei-Bin Xiao, Hua Li and Chuang Lu
      Drug Metabolism and Disposition November 2013, 41 (11) 1914-1922; DOI: https://doi.org/10.1124/dmd.113.053199
  4. Zhuang, Xiao-Mei

    1. You have access
      Identification and Characterization of Psoralen and Isopsoralen as Potent CYP1A2 Reversible and Time-Dependent Inhibitors in Human and Rat Preclinical Studies
      Xiao-Mei Zhuang, Yu-Huan Zhong, Wei-Bin Xiao, Hua Li and Chuang Lu
      Drug Metabolism and Disposition November 2013, 41 (11) 1914-1922; DOI: https://doi.org/10.1124/dmd.113.053199
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 41 (11)
Drug Metabolism and Disposition
Vol. 41, Issue 11
1 Nov 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics